SGS Pharma Clinical Research is a leading CRO specializing in early-stage development and functional biometrics (Phases I–IV). With a strong presence in Europe and the Americas, SGS offers a comprehensive range of clinical trial services, including full early-phase drug development consultancy, clinical project management and monitoring, and biometrics, as well as medical safety and regulatory services. SGS operates its own clinical pharmacology unit in Belgium featuring a viral challenge testing facility and a phase I patient unit based in Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a strong therapeutic focus on Infectious Diseases, Vaccines, Respiratory, Dermatology and Oncology.